Healthy Volunteers Clinical Trial
Official title:
Physiological and Psychosomatic Effects of Exposure to MRI Scanning Environment
Background:
- Magnetic resonance imaging (MRI) creates high-quality images of the human body without
x-rays. It uses a strong magnetic field and radio waves to take pictures. Researchers want to
test a scanner that uses a high magnetic field strength.
Objective:
- To study how the body responds to being in a high field 11.7T MRI scanner.
Eligibility:
- Healthy people ages 22 65.
Design:
- Participants will be screened with a medical history and physical exam. They will
complete a healthy volunteer questionnaire and an MRI safety screening form. They may
have a 3T MRI scan of the brain.
- Participants will have an MRI scan. They will lie on a table that will slide in and out
of the MRI cylinder very slowly. They will be asked to lie still.
- Participants will do simple tasks while inside the machine. These can include listening
and responding to questions, tapping fingers, or moving a hand.
- While in the scanner, participants will hear loud knocking noises. They will get
earmuffs.
- Right when they exit the scanner, participants will get a questionnaire to fill out.
This will ask about how they felt inside the scanner.
- During the MRI, participants heart rate, respiratory rate, and skin temperature will be
measured. Before and after the scan, these things plus blood pressure will be measured.
- Participants will be tested before and after being in the MRI scanner. They will answer
questions, take pen-and-paper or computer tests, and do simple actions. Their sense of
smell may be tested.
Objective
The goals of this pilot study are to establish a normative database of vital signs, cognitive
function and unusual subjective sensations in a 0T scanner. This data will be used as a
reference for a future study of the effects of exposure to a 11.7T static magnetic field.
Study Population
26 healthy volunteers, aged 22-65.
Accrual ceiling =50
Accrual Target =26
Drop outs will be replaced
Design
The study consists of one outpatient screening session and one experimental session. Informed
consent and a history and neurological examination will be carried out at the screening
visit. Vital signs (pulse oximeter, heart rate, respiratory rate and skin temperature) will
be measured immediately before and after the experimental scan session, and pulse oximeter,
heart rate and respiration will be monitored when the subject is in the scanner. Subjects
will remain in the scanner for approximately 1 hour. During the experimental session, while
the subject is in the scanner, they will be asked to carry out a brief test of attention at
10-15 minute intervals, up to 3 times during the session. At the end of the experimental
session, subjects will fill out the MRI exit questionnaire to rate subjective sensations such
as nausea, vertigo, and lightheadedness, on a Likert scale and complete a computerized
neuro-cognitive test battery.
Outcome Measures
The objective of the study is to obtain a normative dataset of neuropsychological test
measures, physiological parameters, and subjective experiences measures in subjects
undergoing 0T exposure.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |